Clopidogrel is a platelet aggregation inhibitor widely administered to atherosclerotic patients with the risk of a heart attack or stroke that are caused by the formation of a clot in the blood. Plavix (clopidogrel bisulfate) is marketed worldwide in nearly 110 countries, with sales of $6.4 billion per year. It had been the second top selling drug in the world for a few years and was still growing by over 20%. Methyl (R)-2-chloromandelate is key intermediate of clopidogrel and should be enantiopure. Considering the enantioselective nature of enzyme, biological transformation of ketones into optically active alcohols could be an efficient strategy. In the present study, we investigate the factors that influence the reduction of methyl-2-chlorobenzoylformate to find optimum conditions enabling the efficient production of methyl (R)-2-chloromandelate. [This work was supported by the Small & Medium Business Administration].
한국생물공학회 [The Korean Society for Biotechnology and Bioengineering]
설립연도
1984
분야
공학>생물공학
소개
이 법인은 생물 공학의 발전과 보급에 이바지하고, 회원 상호 간의 연구 협력과 친목을 도모함을 목적으로 한다
1. 생물공학 분야의 발전을 위한 연구 협력
2. 생물공학의 실용화를 촉진시키기 위한 산학 협동
3. 학술연구 발표회, 강연회, 연수회 등 학술활동의 개최
4. 국,영문 학술지,소식지,학술회의 Proceedings 및 학술도서의 발간
5. 생물공학 발전을 위한 정책 건의
6. 기타 국제 교류 등 본 학회의 목적 달성을 위한 제반 활동